See what you missed at ASRM 2024 with the ASRM 2024 Recorded Bundle 

Menu
Close Close Icon

Updated terminology for gamete and embryo donors: directed (identified) to replace ‘‘known’’ and nonidentified to replace ‘‘anonymous’’: a committee opinion (2022)


Gamete and embryo donation have historically been characterized as known or anonymous. The terminology reflected what was true at one time; donors and recipients either knew one another or did not at the time of the donation. For those who were unknown to each other at the time of the donation, the expectation was that this anonymity would continue indefinitely. The identity of anonymous donors was protected by both clinical protocols and, to varying degrees, legislation intended to address legal parentage of recipients and non-parentage of donors.

Social media, changing mores, and more recently significantly broader access to direct-to-consumer deoxyribonucleic acid (DNA) testing (DTC DNA) have all contributed to a new reality that expectations of donor anonymity can no longer be assured. It is estimated that at the present time, tens of millions of Americans have their genetic information stored in privately owned and largely unregulated databases (1).

Other modalities such as facial recognition have also recently become refined and more accurate (2). These technologies have introduced a means by which donor-conceived offspring and those to whom they have genetic ties may identify, locate, and contact one another. It should be noted that individuals who donated gametes or embryos, or who are donor conceived, may be traceable even if they never enroll in any DNA testing program themselves. This may occur if others with genetic ties to them participate in DTC DNA programs that allow for the identification of those to whom they are genetically linked (3). The era of perpetual donor anonymity has ended. This loss of anonymity has the potential to affect both current and past donations, including donors, recipients, donor-conceived offspring, and those who are genetically linked to them. While donor identity can still be withheld at the time of a donation, the discovery of genetic relationships leading to gamete and embryo donor identification may occur both outside the control of medical professionals and indefinitely into the future.

These emerging genetic and technological realities have changed the landscape of gamete and embryo donation, necessitating a concomitant change in the language used to describe these donations and in the counseling of those who participate in them.

As such, the American Society for Reproductive Medicine has changed the nomenclature of gamete and embryo donation. Donors who were previously described as known will now be referred to as directed (identified) donors, and those previously described as anonymous will be referred to as non- identified donors.

DIRECTED DONORS

The choice of the term directed (identified) donor, previously called known donor, was selected to align with the Food and Drug Administration (FDA) regulations (4). The gametes from a directed (identified) donor who is deemed ‘‘ineligible’’ based on FDA guidance for tissue donation may in some cases be used if both parties are aware of the theoretical infectious or genetic risks to the recipient(s) and offspring and consent to move forward with the donation (5). The  categorization of an individual as a directed (identified) donor affords recipients the option of waiving some exclusion criteria when they value the benefits of the known donor (e.g., sister to sister egg donation) so strongly that they are willing to accept the presumably low risk of infectious disease transmission. The use of the term directed (identified) mirrors the FDA language that specifies exclusions and exceptions for gamete and embryo donation based on whether the parties are known to one another. The new terminology should assist physicians and administrators as they interpret and apply the FDA regulations to clinical practice.

NONIDENTIFIED DONORS

The choice of the term nonidentified for those who were previously called anonymous donors acknowledges the intention of all involved in the donation process, including donors and recipients, as well as any medical, professional, or coordinating entities or professionals, not to share identifying information of the donor or recipient with one another. The intention at the time a nonidentified donation contract is entered into, or the donation undertaken, is that the identities of the donor, recipient, and any resulting offspring will remain unknown to one another to the extent permitted under law or to an explicit and limited degree, such as when a contract or consent document may allow for arranging contact between the donor-conceived offspring and the donor upon the offspring reaching a specific age, often the age of majority. These latter types of arrangements are sometimes referred to as open-identity arrangements, and the donors who agree to them are referred to as open-identity donors.

Example of unplanned identification (Figure 1): Family A: Use of donor gamete never disclosed to child. Family B: ‘‘Anonymous’’ gamete donation never disclosed by the donor. Children A and B: Independently send DNA to a DTC DNA Laboratory without parental knowledge. Each is notified about a 1/2 sibling. Difficult conversations ensue.
fig1-Updated terminology for.PNG
This scenario applies equally to egg, sperm, and embryo donation. Furthermore, it need not be the donor-conceived offspring who participate; it could be other genetically related individuals. Finally, in cases of directed gamete donation, where the donor and recipient are known to one another, the parties involved will want to consider who are the other genetic relatives that should be made privy to the information, as they may inadvertently find out about the donation at some future date if they participate in genetic testing.

CONCLUSION

In conclusion, given a multitude of global social media platforms, increasingly accessible and used DTC DNA services, and facial recognition technology, true anonymity between donors and recipients can no longer be guaranteed. All parties involved in gamete and embryo donation should be aware that identities may be discovered by the resulting offspring and other genetically linked individuals at any future time. This holds for both directed (identified) and nonidentified do- nations. Complicating matters is the fact that past donors, whether they donated with the intention of anonymity or not, are now potentially discoverable at any future date. The extent to which such revelations will occur is unknown. A 2019 estimate suggested that approximately 8% of the US population had already sent DNA to a DTC DNA vendor with speculation that the number could more than triple over the next several years, thus greatly expanding the population of people who can identify one another based on their genetic links (6). A related, but somewhat different, scenario is the active pursuit of connection among offspring who know they were conceived from donor gametes or embryos (7).

The impact that this will have on those being discovered and whether this current reality will change the willingness of individuals to serve as gamete or embryo donors remain to be seen. The collateral effects on genetically linked individuals much removed from the donation process are also unknown but will become clearer over time. Critical to the donation process is the informed consent of donors and recipients regarding the possibility that genetically linked individuals may identify one another, both intentionally and otherwise, at any future date.

Physicians and those who arrange gamete and embryo donation should provide maximum transparency regarding the limits of anonymity to all known stakeholders at the time of the donation, beginning with the change in nomenclature when referring to directed (identified) and nonidentified gamete and embryo donors.

Acknowledgments: This report was developed under the direction of the Practice and Ethics Committees of the American Society for Reproductive Medicine (ASRM) as a service to its members and other practicing clinicians. Although this document reflects appropriate management of a problem encountered in the practice of reproductive medicine, it is not intended to be the only approved standard of practice or dictate an exclusive course of treatment. Other plans of management may be appropriate, taking into account the needs of the individual patient, available resources, and institutional or clinical practice limitations. The Practice and Ethics Committees and the Board of Directors of the American Society for Reproductive Medicine have approved this report.

This document was reviewed by the ASRM members, and their input was considered in the preparation of the final document. The following members of the ASRM Practice and Ethics Committees participated in the development of this document: Alan Penzias, MD; Kristin Bendikson, MD; Marcelle I. Cedars, MD; Tommaso Falcone, MD; Karl Hansen, MD, PhD; Micah Hill, DO; Sangita Jindal, PhD; Suleena Kalra, MD, MSCE; Jennifer Mersereau, MD; Catherine Racowsky, PhD; Richard Reindollar, MD; Chevis N Shannon, DrPH, MPH, MBA; Anne Steiner, MD, MPH; Cigdem Tanrikut, MD; Michael Thomas, MD; Belinda Yauger, MD; Sigal Klipstein, MD; Deborah Anderson; Kavita Shah Arora, MD, MBE; Tolulope Bakare, MD; Katherine Cameron, MD; Susan Crockin, JD; Ruth Farrell, MD; Catherine Hammack-Aviran, MA, JD; Mandy Katz-Jaffe, PhD; Jennifer Kawwass, MD; Ed- ward Martinez, MD; Joshua Morris, MD; Robert Rebar, MD; Eli Reshef, MD; Chevis N Shannon, DrPH, MPH, MBA; Hugh Taylor, MD; Sean Tipton, MA; and Julianne Zweifel, PhD. All Committee members disclosed commercial and financial relationships with manufacturers or distributors of goods or services used to treat patients. The members of the Committees who were found to have conflicts of interest based on the relationships disclosed did not participate in the discussion or development of this document.

REFERENCES

  1. Regalado A. 2017 was the year consumer DNA testing blew up. Available at: https://www.technologyreview.com/2018/02/12/145676/2017-was-the-year- consumer-dna-testing-blew-up/. Accessed March 23, 2022.
  2. Harwell D. This facial recognition website can turn anyone into a cop—or a stalker. Available at: https://www.washingtonpost.com/technology/2021/ 05/14/pimeyes-facial-recognition-search-secrecy. Accessed March 23, 2022.
  3. 23andMe Customer Care. What unexpected things might I learn from 23andMe?. Available at: https://customercare.23andme.com/hc/en-us/ articles/202907980. Accessed March 23, 2022.
  4. US Food and Drug Administration. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products: guidance for industry. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance- documents/eligibility-determination-donors-human-cells-tissues-and- cellular-and-tissue-based-products. Accessed March 23, 2022.
  5. Practice Committee of the American Society for Reproductive Medicine, Practice Committee for the Society for Assisted Reproductive Technology. Guidance regarding gamete and embryo donation. Fertil Steril 2021;115:1395–410.
  6. Regalado A. More than 26 million people have taken an at-home ancestry test. Available at: https://www.technologyreview.com/2019/02/11/103446/ more-than-26-million-people-have-taken-an-at-home-ancestry-test. Ac- cessed March 23, 2022.
  7. Dominus S. Sperm donors can’t stay secret any more. Here’s what that means. Available at: https://www.nytimes.com/2019/06/26/magazine/sperm-donor- questions.html. Accessed March 23, 2022.

Ethics Opinions

Ethics Committee Reports are drafted by the members of the ASRM Ethics Committee on the tough ethical dilemmas of reproductive medicine.
Ethics Committee teaser

Use of preimplantation genetic testing for monogenic adult-onset conditions: an Ethics Committee opinion (2024)

Preimplantation genetic testing for adult-onset monogenic diseases is ethically allowed when fully penetrant or conferring disease predisposition.
Ethics Committee teaser

Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)

The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled.
Ethics Committee teaser

Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2023)

Financial ‘‘risk-sharing’’ fee structures in programs charge patients a higher initial fee but provide reduced fees for subsequent cycles.
Ethics Committee teaser

Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)

Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility.

Practice Documents

ASRM Practice Documents have been developed to assist physicians with clinical decisions regarding the care of their patients.
Practice Committee Documents teaser

Maternal cardiovascular morbidity and mortality associated with pregnancy in individuals with Turner syndrome: a committee opinion (2024)

In individuals with Turner syndrome, the risk of death from aortic dissection or rupture during pregnancy may be as high as 1%, and it is unclear whether this risk persists during the postpartum period owing to pregnancy-related aortic changes. 
PracticeDocument_Teaser.webp

The use of preimplantation genetic testing for aneuploidy: a committee opinion (2024)

PGT-A use in the U.S. is rising, but its value as a routine IVF screening test is unclear, with mixed results from various studies.
PracticeDocument_Teaser.webp

Evidence-based diagnosis and treatment for uterine septum: a guideline (2024)

To provide evidence-based recommendations regarding the diagnosis and effectiveness of surgical treatment of a uterine septum.
PracticeDocument_Teaser.webp

The use of hormonal contraceptives in fertility treatments: a committee opinion (2024)

Hormonal contraception aids in the timing of ART cycles, reduce ovarian cysts at IVF cycle initiation, and optimize visualization before hysteroscopy.

More Resources

MAC 2021 teaser
ASRM Academy on the Go

ASRM MAC Tool 2021

The ASRM Müllerian Anomaly Classification 2021 (MAC2021) includes cervical and vaginal anomalies and standardize terminology within an interactive tool format.

View the MAC Tool
EMR Phrases teaser
Practice Guidance

EMR Shared Phrases/Template Library

This resource includes phrases shared by ASRM physician members to provide a template for individuals to create their own EMR phrases.

View the library
Practice Committee Documents teaser

ASRM Practice Documents

These guidelines have been developed by the ASRM Practice Committee to assist physicians with clinical decisions regarding the care of their patients.

View ASRM Practice Documents
Ethics Committee teaser

ASRM Ethics Opinions

Ethics Committee Reports are drafted by the members of the ASRM Ethics Committee on the tough ethical dilemmas of reproductive medicine.

View ASRM Ethics Opinions
Coding Corner general teaser
Practice Guidance

Coding Corner Q & A

The Coding Corner Q & A is a list of previously submitted and answered questions from ASRM members about coding. Answers are available to ASRM Members only.

View the Q & A
Covid-19 teaser
Practice Guidance

COVID-19 Resources

A compendium of ASRM resources concerning the Novel Corona virus (SARS-COV-2) and COVID-19.

View the resources
Couple looking at laptop for online patient education materials

Patient Resources

ReproductiveFacts.org provides a wide range of information related to reproductive health and infertility through patient education fact sheets, infographics, videos, and other resources.

View Website

Topic Resources

View more on the topic of egg donation
Videos Icon

Hormonal Induction of Endometrial Receptivity for Fresh or Frozen Embryo Transfer​ Part I

Explore Dr. Paulson's insights on endometrial receptivity and hormonal preparation in IVF, egg donation, and surrogacy, highlighting estrogen and progesterone roles. View the ASRMed Talk Video
Coding Icon

Mental health assessment for donors and intended parents

Is it appropriate to use 96156 or 96167 for mental health professional (MHP) counseling of gamete/embryo donors and gestational carriers? View the Answer
Document Icon

Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)

The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Coding Icon

Diagnosis code for donation

What is the diagnosis code for an embryo donation versus egg donation? View the Answer
Coding Icon

Mandated states and egg retrieval

What name should you use to submit for reimbursement for the actual egg donor when there is benefit for the donor egg retrieval? View the Answer
Coding Icon

Reimbursement for donor egg

My wife and I are going through a fertility treatment process, and we have purchased a donor egg out-of-pocket from a donor bank.  View the Answer
Videos Icon

Modernizing Clinic Options for Directed Gamete and Embryo Donation

Explore the evolution of gamete insemination laws, ethics, and rights for donor-conceived individuals from 1884 to present-day privacy shifts. View the ASRMed Talk Video
Document Icon

Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)

In some instances, it is permissible for the physician to disclose information to the affected party or to decline to provide or continue to provide care. View the Committee Opinion
Coding Icon

Reimbursement for cost of donor egg

My wife and I are going through a fertility treatment process, and we have purchased a donor egg out-of-pocket from a donor bank.  View the Answer
Coding Icon

Billing egg donor’s retrieval to recipient’s insurance

How you would bill an egg donor’s retrieval to a patient’s insurance? View the Answer
Coding Icon

Psychological Evaluation

Many REs require patients (and their spouses/partners) who are considering using donor gametes to see an infertility counselor first. View the Answer
Coding Icon

IVF Case Rates

What ICD-10 codes apply to case rates? View the Answer
Coding Icon

Diagnosis Code For Same-Sex Egg Donation

We have a same-sex male couple with insurance coverage for IVF.  View the Answer
Coding Icon

Donor Egg Infectious Disease Lab Screening

The issue we are experiencing is outside labs billing with Z11.3 are getting denials stating improper ICD-10 for the services billed.  View the Answer
Coding Icon

Donor Egg Lot Acquisition

What is the code for egg lot acquisition? View the Answer
Coding Icon

Donor Eggs-Physical Exam

Is there a specific CPT code used for Donor Physical Exams or would a practice just bill using the appropriate E&M Code?  View the Answer
Coding Icon

Donor Egg-Retrieval On Recipient's Claim

Is the donor egg retrieval included on the bill to insurance with the first IVF treatment for the recipient?  View the Answer
Coding Icon

Donor Embryos

Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Coding Icon

Donor Screening

Is there a specific CPT code used for Donor Physical Exams or would a practice just bill using the appropriate E&M Code?  View the Answer
Coding Icon

Egg Culture and Fertilization: Same Gender

A same-sex male couple requested half their donor eggs be fertilized with sperm from male #1 and the other half fertilized from male #2. View the Answer
Coding Icon

Claim Form for Donor Egg Retrieval

What bill form is used of IVF donor egg retrieval? View the Answer
Coding Icon

Coding For Donor Egg Retrieval For Male Intended Parent

In coding a donor-egg retrieval to bill to insurance under the male intended parent, would it be appropriate to use the Z31.83?  View the Answer
Document Icon

Financial compensation of oocyte donors: an Ethics Committee opinion (2023)

Financial compensation of women donating oocytes for reproductive or research purposes is justified on ethical grounds. View the Committee Opinion
Document Icon

Guidance regarding gamete and embryo donation (2021)

This document provides the latest recommendations for the evaluation of potential sperm, oocyte, and embryo donors as well as their recipients. View the Committee Opinion
Document Icon

Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline (2021)

A review of success rates, factors that may impact success rates, and  outcomes. View the Committee Opinion
Document Icon

Repetitive oocyte donation: a committee opinion (2020)

Donors should be advised of the number of cycles/donations that a given oocyte donor may undergo. View the Committee Opinion
Document Icon

Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion (2016)

Advanced reproductive age (ARA) is a risk factor for female infertility, pregnancy loss, fetal anomalies, stillbirth, and obstetric complications.  View the Committee Opinion

Topic Resources

View more on the topic of embryo donation
Videos Icon

Modernizing Clinic Options for Directed Gamete and Embryo Donation

Explore the evolution of gamete insemination laws, ethics, and rights for donor-conceived individuals from 1884 to present-day privacy shifts. View the ASRMed Talk Video
Document Icon

Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)

In some instances, it is permissible for the physician to disclose information to the affected party or to decline to provide or continue to provide care. View the Committee Opinion
Document Icon

Defining embryo donation: an Ethics Committee opinion (2023)

The ethical appropriateness of patients donating embryos to other patients for  family building, or for research, is well established.
View the Committee Opinion
Coding Icon

IVF Case Rates

What ICD-10 codes apply to case rates? View the Answer
Coding Icon

Donor Embryos

Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Document Icon

Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion (2019)

This Ethics Committee report outlines the interests, obligations, and rights of all parties involved in gamete and embryo donation. View the Committee Opinion
Document Icon

Guidance regarding gamete and embryo donation (2021)

This document provides the latest recommendations for the evaluation of potential sperm, oocyte, and embryo donors as well as their recipients. View the Committee Opinion
Document Icon

Informing offspring of their conception by gamete or embryo donation: an Ethics Committee opinion (2018)

This document discusses the ethical implications of informing offspring about their conception using gamete or embryo donation. View the Committee Opinion
Document Icon

Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion (2016)

Advanced reproductive age (ARA) is a risk factor for female infertility, pregnancy loss, fetal anomalies, stillbirth, and obstetric complications.  View the Committee Opinion

Topic Resources

View more on the topic of sperm donation
Document Icon

Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)

The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Videos Icon

Modernizing Clinic Options for Directed Gamete and Embryo Donation

Explore the evolution of gamete insemination laws, ethics, and rights for donor-conceived individuals from 1884 to present-day privacy shifts. View the ASRMed Talk Video
Document Icon

Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)

In some instances, it is permissible for the physician to disclose information to the affected party or to decline to provide or continue to provide care. View the Committee Opinion
Coding Icon

Psychological Evaluation

Many REs require patients (and their spouses/partners) who are considering using donor gametes to see an infertility counselor first. View the Answer
Coding Icon

IVF Case Rates

What ICD-10 codes apply to case rates? View the Answer
Coding Icon

Donor Sperm IUI Single Women

How do I code for therapeutic donor insemination for an unmarried female with no known fertility issues except no partner? View the Answer
Document Icon

Guidance regarding gamete and embryo donation (2021)

This document provides the latest recommendations for the evaluation of potential sperm, oocyte, and embryo donors as well as their recipients. View the Committee Opinion